These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
361 related items for PubMed ID: 29204272
1. Novel antibiotic combinations proposed for treatment of Burkholderia cepacia complex infections. El-Halfawy OM, Naguib MM, Valvano MA. Antimicrob Resist Infect Control; 2017; 6():120. PubMed ID: 29204272 [Abstract] [Full Text] [Related]
2. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis. Kitt H, Lenney W, Gilchrist FJ. BMC Pharmacol Toxicol; 2016 Mar 28; 17():14. PubMed ID: 27018049 [Abstract] [Full Text] [Related]
4. Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy? Horsley A, Webb K, Bright-Thomas R, Govan J, Jones A. Front Cell Infect Microbiol; 2011 Mar 28; 1():18. PubMed ID: 22919584 [Abstract] [Full Text] [Related]
5. Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients. Papp-Wallace KM, Becka SA, Zeiser ET, Ohuchi N, Mojica MF, Gatta JA, Falleni M, Tosi D, Borghi E, Winkler ML, Wilson BM, LiPuma JJ, Nukaga M, Bonomo RA. ACS Infect Dis; 2017 Jul 14; 3(7):502-511. PubMed ID: 28264560 [Abstract] [Full Text] [Related]
6. Ceftazidime plasma concentration in a patient with cystic fibrosis treated with ceftazidime/avibactam plus trimethoprim/sulfametoxazole for Bulkholderia cepacia reacutization. Saffioti C, Barco S, Cangemi G, Mesini A, Casciaro R, Cresta F, Castellani C, Bandettini R, Morelli P, Castagnola E. J Chemother; 2019 Jul 14; 31(7-8):436-438. PubMed ID: 31583970 [No Abstract] [Full Text] [Related]
12. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation. Horsley A, Jones AM. Cochrane Database Syst Rev; 2012 Oct 17; 10():CD009529. PubMed ID: 23076960 [Abstract] [Full Text] [Related]
13. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection. Martina P, Feliziani S, Juan C, Bettiol M, Gatti B, Yantorno O, Smania AM, Oliver A, Bosch A. Int J Med Microbiol; 2014 Nov 17; 304(8):1182-91. PubMed ID: 25217078 [Abstract] [Full Text] [Related]
15. Management of initial colonisations with Burkholderia species in France, with retrospective analysis in five cystic fibrosis Centres: a pilot study. Gruzelle V, Guet-Revillet H, Segonds C, Bui S, Macey J, Chiron R, Michelet M, Murris-Espin M, Mittaine M. BMC Pulm Med; 2020 Jun 05; 20(1):159. PubMed ID: 32503487 [Abstract] [Full Text] [Related]